Tarcine BioMed attended the 66th American Association for Clinical Chemistry (AACC) Annual Meeting & Clinical Lab Expo in Chicago during July 29-31, 2014. Started from last year in Huston, Tarcine BioMed has been a proud exhibitor at AACC expo.
As the world’s largest exposition for clinical laboratory products and services, the AACC Annual Meeting & Clinical Lab Expo attracts more than 20,000 professionals from over 110 countries every year. 80% of attendees play a role in the purchase of products and services for the lab. This is a great platform for new products release, seeking collaboration partners, as well as information exchange.
Tarcine products in early screening of cancer, myocardial infarction warning, and infectious disease testing are Chinese FDA approved. The lead product NPcheck, the only test kit approved by Chinese FDA for adjuvant diagnostic and clinical management of Nasopharyngeal Carcinoma, is also CE marked.
During this expo, Tarcine BioMed team had extensive communications with many companies from various countries including introducing Tarcine and its products to booth visitors as well as exploring collaboration opportunities with global partners.